Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan-Reference-Cited by-同舟云学术

Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan

Published:2018-06 Issue: Volume:15 Page:55-63
ISSN:2214-4269
Container-title:Molecular Genetics and Metabolism Reports
language:en
Short-container-title:Molecular Genetics and Metabolism Reports

Author:

Yamada Kenji^ORCID,Shiraishi Hideaki,Oki Eishin,Ishige Mika,Fukao Toshiyuki,Hamada Yusuke,Sakai Norio^ORCID,Ochi Fumihiro,Watanabe Asami,Kawakami Sanae^ORCID,Kuzume Kazuyo,Watanabe Kenji,Sameshima Koji,Nakamagoe Kiyotaka^ORCID,Tamaoka Akira,Asahina Naoko,Yokoshiki Saki,Miyakoshi Takashi,Ono Kota,Oba Koji,Isoe Toshiyuki,Hayashi Hiroshi,Yamaguchi Seiji,Sato Norihiro

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology

Reference26 articles.

1. Mitochondrial fatty-acid oxidation disorders;Kompare;Semin. Pediatr. Neurol.,2008

2. Fatty acid oxidation disorders: outcome and long-term prognosis;Wilcken;J. Inherit. Metab. Dis.,2010

3. Pathophysiology of fatty acid oxidation disorders;Bennett;J. Inherit. Metab. Dis.,2009

4. Fatty acid oxidation disorders;Rinaldo;Annu. Rev. Physiol.,2002

5. The mechanisms of action of PPARs;Berger;Annu. Rev. Med.,2002

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACAD9 treatment with bezafibrate and nicotinamide riboside temporarily stabilizes cardiomyopathy and lactic acidosis;Mitochondrion;2024-09

2. Stealthy progression of type 2 diabetes mellitus due to impaired ketone production in an adult patient with multiple acyl-CoA dehydrogenase deficiency;Molecular Genetics and Metabolism Reports;2024-03

3. Clinical and Gene Analysis of Fatty Acid Oxidation Disorders Found in Neonatal Tandem Mass Spectrometry Screening;Pharmacogenomics and Personalized Medicine;2023-06

4. Peroxisome proliferator-activated receptor (PPAR) agonists as a potential therapy for inherited metabolic disorders;Biochemical Pharmacology;2023-03

5. Nutrigenomics in the management and prevention of metabolic disorders;Role of Nutrigenomics in Modern-day Healthcare and Drug Discovery;2023